Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
| ▸ | POLB | P06746 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2185353 | 1.00 | LMNA (0.57) | LMNAPOLBKMT2AMEN1CA9 | |
| Water SCHEMBL11590419 | 0.98 | LMNA (0.55) | LMNAPOLBKMT2AMEN1CA9 | |
| Acetic Acid SCHEMBL8202609 | 0.91 | LMNA (0.53) | LMNAPOLBKMT2AMEN1CA9 | |
| SCHEMBL16255397 | 0.88 | FURIN (0.50) | LMNAPOLBKMT2AMEN1CA9 | |
| SCHEMBL14298196 | 0.87 | CA9 (0.52) | LMNAPOLBKMT2AMEN1CA9 | |
| SCHEMBL12360950 | 0.87 | CA9 (0.52) | LMNAPOLBKMT2AMEN1CA9 | |
| Chlorobenzene SCHEMBL28114087 | 0.84 | TSHR (0.48) | LMNAPOLBKMT2AMEN1CA9 | |
| SCHEMBL13645704 | 0.79 | CA9 (0.47) | LMNAPOLBKMT2ACA9CYP1A2 | |
| SCHEMBL6734907 | 0.78 | LMNA (0.61) | LMNAPOLBKMT2AMEN1CA9 | |
| SCHEMBL11461631 | 0.78 | LMNA (0.55) | LMNAPOLBKMT2AMEN1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114835660-B | Preparation method of oxime ether | 浙江理工大学 | 2024-03-22 | — | — | CN | claimed |
| CN-112574135-B | 4-aryl-5-thioether-2-difluoromethyl oxazole, and derivatives and synthesis method thereof | 湖南工程学院 | 2022-09-23 | — | — | CN | claimed |
| US-20210157242-A1 | PHOTORESIST-REMOVING LIQUID AND PHOTORESIST-REMOVING METHOD | HUAYING RESEARCH CO., LTD (CN) | 2021-05-27 | — | — | US | claimed |
| CN-112574135-A | 4-aryl-5-thioether-2-difluoromethyl oxazole, and derivatives and synthesis method thereof | 湖南工程学院 | 2021-03-30 | — | — | CN | claimed |
| CN-108355709-B | Application of bismuth trifluoromethanesulfonate as Beckmann rearrangement reaction catalyst | 嘉兴学院 | 2020-12-08 | — | — | CN | claimed |
| EP-3663857-A1 | PHOTORESIST STRIPPING SOLUTION AND METHOD OF STRIPPING PHOTORESIST | Huaying Research Co., Ltd (CN) | 2020-06-10 | — | — | EP | claimed |
| CN-110294758-A | 2- replaces 5,6- dihydro-pyrazolo [5,1- α] isoquinolin, derivative and its synthetic method | 湘潭大学 | 2019-10-01 | — | — | CN | claimed |
| CN-109705146-A | 2- amino benzo [4,5] thieno [3,2-d] thiazole, derivative and its synthetic method | 湘潭大学 | 2019-05-03 | — | — | CN | claimed |
| CN-108822135-A | A kind of synthetic method of the cyclosubstituted thieno of azepine [3,2-d] thiazole and its derivative | 湘潭大学 | 2018-11-16 | — | — | CN | claimed |
| CN-108355709-A | Purposes of the Bismuth triflate as Beckmann rearrangement catalyst | 嘉兴学院 | 2018-08-03 | — | — | CN | claimed |
| CN-107721872-A | A kind of method that ketoxime Beckmann rearrangement prepares acid amides | 浙江农林大学 | 2018-02-23 | — | — | CN | claimed |
| CN-106146350-B | A kind of new method of synthesizing amino formic acid oxime ester derivative | 华南理工大学 | 2017-10-20 | — | — | CN | claimed |
| CN-107011201-A | Preparation method of amide | 南京工业大学 | 2017-08-04 | — | — | CN | claimed |
| CN-106146350-A | A kind of new method of synthesizing amino methylcarbamoyl oximino ester derivant | 华南理工大学 | 2016-11-23 | — | — | CN | claimed |
| CN-1660822-A | Oxime functionalized new type compound of kinitrogen cyclic amine and synthetic method | TIANJIN TEACHER S UNIV (CN) | 2005-08-31 | — | — | CN | claimed |
| US-20030215929-A1 | Rhodococcus gene encoding aldoxime dehydratase | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-11-20 | — | — | US | claimed |
| EP-0343791-B1 | STABILITY-IMPROVED TRIOXANE COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1992-07-29 | — | — | EP | claimed |
| US-5026875-A | Having ketoxime stabilizers; nondegradating, nonpolymerizing, formaldehyde-free | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1991-06-25 | — | — | US | claimed |
| EP-0343791-A1 | Stability-improved trioxane composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1989-11-29 | — | — | EP | claimed |
| CN-114835660-B | Preparation method of oxime ether | 浙江理工大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-115368258-B | Preparation process of amide compound | 浙江工业大学 | 2023-07-25 | — | — | CN | disclosed |
| CN-112574135-B | 4-aryl-5-thioether-2-difluoromethyl oxazole, and derivatives and synthesis method thereof | 湖南工程学院 | 2022-09-23 | — | — | CN | disclosed |
| US-11448966-B2 | Photoresist-removing liquid and photoresist-removing method | HUAYING RESEARCH CO., LTD (CN) | 2022-09-20 | — | — | US | disclosed |
| CN-114835660-A | Preparation method of oxime ether | 浙江理工大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-110606855-B | Polysubstituted benzothienoisoquinoline, derivative and synthesis method thereof | 湘潭大学 | 2022-03-18 | — | — | CN | disclosed |
| US-20210157242-A1 | PHOTORESIST-REMOVING LIQUID AND PHOTORESIST-REMOVING METHOD | HUAYING RESEARCH CO., LTD (CN) | 2021-05-27 | — | — | US | disclosed |
| CN-112574135-A | 4-aryl-5-thioether-2-difluoromethyl oxazole, and derivatives and synthesis method thereof | 湖南工程学院 | 2021-03-30 | — | — | CN | disclosed |
| CN-108355709-B | Application of bismuth trifluoromethanesulfonate as Beckmann rearrangement reaction catalyst | 嘉兴学院 | 2020-12-08 | — | — | CN | disclosed |
| EP-3663857-A1 | PHOTORESIST STRIPPING SOLUTION AND METHOD OF STRIPPING PHOTORESIST | Huaying Research Co., Ltd (CN) | 2020-06-10 | — | — | EP | disclosed |
| CN-111039867-A | Green synthesis method of 3, 4-disubstituted isoquinoline derivative promoted by room-temperature illumination | 四川大学 | 2020-04-21 | — | — | CN | disclosed |
| CN-107011201-B | A kind of preparation method of amide | 南京工业大学 | 2019-11-22 | — | — | CN | disclosed |
| CN-109705146-A | 2- amino benzo [4,5] thieno [3,2-d] thiazole, derivative and its synthetic method | 湘潭大学 | 2019-05-03 | — | — | CN | disclosed |
| CN-109686664-A | A kind of minimizing technology of photoresist removal liquid and photoresist containing tetra-alkyl ammonium hydroxide | 无锡华瑛微电子技术有限公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-109388036-A | A kind of minimizing technology for removing liquid and photoresist of photoresist | 无锡华瑛微电子技术有限公司 | 2019-02-26 | — | — | CN | disclosed |
| CN-108822135-A | A kind of synthetic method of the cyclosubstituted thieno of azepine [3,2-d] thiazole and its derivative | 湘潭大学 | 2018-11-16 | — | — | CN | disclosed |
| CN-106478388-B | A method of de- oxime is carried out to aldoxime or ketoxime | 扬州大学 | 2018-09-28 | — | — | CN | disclosed |
| CN-108355709-A | Purposes of the Bismuth triflate as Beckmann rearrangement catalyst | 嘉兴学院 | 2018-08-03 | — | — | CN | disclosed |
| CN-107721872-A | A kind of method that ketoxime Beckmann rearrangement prepares acid amides | 浙江农林大学 | 2018-02-23 | — | — | CN | disclosed |
| CN-106146350-B | A kind of new method of synthesizing amino formic acid oxime ester derivative | 华南理工大学 | 2017-10-20 | — | — | CN | disclosed |
| CN-105037211-B | A kind of threonyl amine carbamate derivative and application | 南开大学 | 2017-08-18 | — | — | CN | disclosed |
| CN-107011201-A | Preparation method of amide | 南京工业大学 | 2017-08-04 | — | — | CN | disclosed |
| CN-106478388-A | A kind of method that aldoxime or ketoxime are carried out with de- oxime | 扬州大学 | 2017-03-08 | — | — | CN | disclosed |
| CN-106146350-A | A kind of new method of synthesizing amino methylcarbamoyl oximino ester derivant | 华南理工大学 | 2016-11-23 | — | — | CN | disclosed |
| CN-105037211-A | Threonyl amine carbamate derivative and application | UNIV NANKAI | 2015-11-11 | — | — | CN | disclosed |
| US-9085508-B2 | Nitric oxide releasing amino acid ester compound, composition and method of use | ORAL DELIVERY TECHNOLOGY LTD. (US) | 2015-07-21 | — | — | US | disclosed |
| EP-1655070-B1 | OXIDATION CATALYST | ASAHI KASEI CHEMICALS CORP (JP) | 2015-07-15 | — | — | EP | disclosed |
| EP-2342175-B1 | NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE | NITROGENIX INC (VG) | 2015-05-27 | — | — | EP | disclosed |
| CN-102219707-B | Acrylpimaric dioxime derivative as well as preparation method and application thereof | INST CHEM IND FOREST PROD CAF | 2014-12-24 | — | — | CN | disclosed |
| US-8846674-B2 | Nitric oxide enhancing prostaglandin compounds, compositions and methods of use | NICOX, S.A. (FR) | 2014-09-30 | — | — | US | disclosed |
| US-20140057873-A1 | NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE | FARBER MICHAEL (US) | 2014-02-27 | — | — | US | disclosed |
| CN-101985424-B | Method for synthesizing o-nitroacetophenone compound | UNIV ZHEJIANG TECHNOLOGY | 2013-05-29 | — | — | CN | disclosed |
| US-8133834-B2 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20120034321-A1 | NITRIC OXIDE ENHANCING PROSTAGLANDIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. | 2012-02-09 | — | — | US | disclosed |
| US-8067464-B2 | Compositions and methods using apocynin compounds and nitric oxide donors | NITROMED, INC. (US) | 2011-11-29 | — | — | US | disclosed |
| US-8067414-B2 | Nitric oxide enhancing prostaglandin compounds, compositions and methods of use | NICOX S.A. (FR) | 2011-11-29 | — | — | US | disclosed |
| CN-102229518-A | Method for preparing aldehyde/ketone through catalytic oxidation | UNIV ZHEJIANG TECHNOLOGY | 2011-11-02 | — | — | CN | disclosed |
| CN-102219707-A | Acrylpimaric dioxime derivative as well as preparation method and application thereof | INST CHEM IND FOREST PROD CAF | 2011-10-19 | — | — | CN | disclosed |
| US-20110195935-A1 | NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE | BENOIT & COTE (CA) | 2011-08-11 | — | — | US | disclosed |
| EP-2342175-A1 | NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE | Nitrogenix Inc. (VG) | 2011-07-13 | — | — | EP | disclosed |
| CN-101985424-A | Method for synthesizing o-nitroacetophenone compound | UNIV ZHEJIANG TECHNOLOGY | 2011-03-16 | — | — | CN | disclosed |
| US-7838023-B2 | Furoxan compounds, compositions and methods of use | NITROMED, INC. (US) | 2010-11-23 | — | — | US | disclosed |
| US-20100240622-A1 | NITRIC OXIDE ENHANCING PROSTAGLANDIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2010-09-23 | — | — | US | disclosed |
| CN-101323584-B | Oxime ether aryl pyrrole compounds having insecticidal, acaricidal and antifungal bioactivity | HUNAN RES INST CHEMICAL IND | 2010-08-25 | — | — | CN | disclosed |
| CN-1835800-B | Oxidation catalyst | ASAHI CHEMICAL CORP (JP) | 2010-04-28 | — | — | CN | disclosed |
| WO-2010034118-A1 | NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE | ORAL DELIVERY TECHNOLOGY LTD. (CA) | 2010-04-01 | — | — | WO | disclosed |
| US-20100069670-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-03-18 | — | — | US | disclosed |
| CN-100579962-C | Arylpyrrole compound with insecticidal, acaricidal and fungicidal biological activity and preparation method thereof | HUNAN RES INST CHEMICAL IND | 2010-01-13 | — | — | CN | disclosed |
| US-20090306027-A1 | GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF THE GENETIC VARIATION OF G-PROTEIN BETA 3 SUBUNIT POLYMORPHISM | NITOMED, INC. (US) | 2009-12-10 | — | — | US | disclosed |
| US-20090253662-A1 | GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF ALDOSTERONE SYNTHASE PROMOTER POLYMORPHISM | NITROMED, INC. (US) | 2009-10-08 | — | — | US | disclosed |
| US-7595313-B2 | Nitric oxide donating diuretic compounds, compositions and methods of use | NICOX, S.A. (FR) | 2009-09-29 | — | — | US | disclosed |
| US-20090215838-A1 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF ANGIOTENSIN II ANTAGONISTS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2009-08-27 | — | — | US | disclosed |
| US-20090203653-A1 | Compositions and Methods Using Apocynin Compounds and Nitric Oxide Donors | NITROMED, INC. (US) | 2009-08-13 | — | — | US | disclosed |
| US-20090192128-A1 | GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF BETA 1 ADRENERGIC RECEPTOR GLY389ARG POLYMORPHISM | NITROMED INC. (US) | 2009-07-30 | — | — | US | disclosed |
| US-20090131342-A1 | Nitrosated and/or nitrosylated compounds, compositions and methods of use | NITROMED, INC. (US) | 2009-05-21 | — | — | US | disclosed |
| EP-1943361-A4 | THE GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF ALDOSTERONE SYNTHASE PROMOTER POLYMORPHISM | NITROMED INC (US) | 2009-04-15 | — | — | EP | disclosed |
| EP-1670459-A4 | NITROSATED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2009-03-25 | — | — | EP | disclosed |
| US-20090075956-A1 | Genetic Risk Assessment in Heart Failure: Impact of the Genetic Variation of NOS3 | NITROMED, INC. (US) | 2009-03-19 | — | — | US | disclosed |
| US-20090053328-A1 | Nitric Oxide Enhancing Glutamic Acid Compounds, Compositions and Methods of Use | NITROMED, INC. (US) | 2009-02-26 | — | — | US | disclosed |
| EP-1668008-A4 | NITROSATED AD NITROSYLATED DIURETIC COMPOUDS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2009-02-25 | — | — | EP | disclosed |
| US-20090048219-A1 | ORGANIC NITRIC OXIDE DONOR SALTS OF NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED INC. (US) | 2009-02-19 | — | — | US | disclosed |
| US-20090042819-A1 | Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use | NITROMED, INC. (US) | 2009-02-12 | — | — | US | disclosed |
| US-20090018091-A1 | Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use | NITROMED, INC. (US) | 2009-01-15 | — | — | US | disclosed |
| US-20090012057-A1 | Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use | NITROMED, INC. (US) | 2009-01-08 | — | — | US | disclosed |
| EP-2010169-A2 | THE GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF THE GENETIC VARIATION OF G-PROTEIN BETA 3 SUBUNIT POLYMORPHISM | Nitromed, Inc. (US) | 2009-01-07 | — | — | EP | disclosed |
| CN-101323584-A | Oxime ether aryl pyrrole compounds having insecticidal, acaricidal and antifungal bioactivity | HUNAN RES INST OF CHEMICAL IND (CN) | 2008-12-17 | — | — | CN | disclosed |
| US-20080306041-A1 | Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use | NICOX S.A. (FR) | 2008-12-11 | — | — | US | disclosed |
| US-20080300292-A1 | Nitrosated and Nitrosylated Compounds, Compositions and Methods for the Treatment of Ophthalmic Disorders | NITROMED, INC (US) | 2008-12-04 | — | — | US | disclosed |
| US-20080293702-A1 | Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use | NITROMED, INC. (US) | 2008-11-27 | — | — | US | disclosed |
| US-20080293678-A1 | Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use | NITROMED, INC. (US) | 2008-11-27 | — | — | US | disclosed |
| US-20080287407-A1 | Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use | NITROMED, INC. (US) | 2008-11-20 | — | — | US | disclosed |
| US-20080275093-A1 | Diuretic Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use | NITROMED, INC. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080268014-A1 | Furoxan Compounds, Compositions and Methods of Use | NITROMED, INC. (US) | 2008-10-30 | — | — | US | disclosed |
| EP-1692107-A4 | NITRIC OXIDE RELEASING PYRUVATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2008-10-29 | — | — | EP | disclosed |
| US-20080255101-A1 | NITRIC OXIDE DONATING DIURETIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2008-10-16 | — | — | US | disclosed |
| EP-1971340-A2 | NITRIC OXIDE ENHANCING PYRUVATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2008-09-24 | — | — | EP | disclosed |
| EP-1968584-A2 | NITRIC OXIDE ENHANCING GLUTAMIC ACID COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2008-09-17 | — | — | EP | disclosed |
| EP-1954685-A2 | FUROXAN COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2008-08-13 | — | — | EP | disclosed |
| EP-1945030-A2 | THE GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF BETA 1 ADRENERGIC RECEPTOR GLY389ARG POLYMORPHISM | Nitromed, Inc. (US) | 2008-07-23 | — | — | EP | disclosed |
| EP-1943361-A2 | THE GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF ALDOSTERONE SYNTHASE PROMOTER POLYMORPHISM | Nitromed, Inc. (US) | 2008-07-16 | — | — | EP | disclosed |
| US-7396829-B2 | such as 2H-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[5-(nitrooxy)pentyl]-, 1,1-dioxide; contains at least one nitric oxide enhancing group; excessive water or electrolyte retention conditions; cardiovascular diseases, and diseases resulting from oxidative or endothelial dysfunctions | NITROMED, INC. (US) | 2008-07-08 | — | — | US | disclosed |
| EP-1814535-A4 | NITROSATED AND NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPHTHALMIC DISORDERS | NITROMED INC (US) | 2008-06-04 | — | — | EP | disclosed |
| EP-1922069-A2 | NITRIC OXIDE ENHANCING ANGIOTENSIN II ANTAGONIST COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2008-05-21 | — | — | EP | disclosed |
| EP-1915157-A2 | NITRIC OXIDE ENHANCING ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2008-04-30 | — | — | EP | disclosed |
| EP-1667643-A4 | NITROSATED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2008-03-05 | — | — | EP | disclosed |
| EP-1883614-A2 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2008-02-06 | — | — | EP | disclosed |
| EP-1877374-A1 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2008-01-16 | — | — | EP | disclosed |
| EP-1865770-A2 | THE GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF THE GENETIC VARIATION OF NOS3 | Nitromed, Inc. (US) | 2007-12-19 | — | — | EP | disclosed |
| EP-1861093-A2 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF ANGIOTENSIN II ANTAGONISTS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2007-12-05 | — | — | EP | disclosed |
| EP-1858863-A1 | CARDIOVASCULAR COMPOUNDS COMPRISING NITRIC OXIDE ENHANCING GROUPS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2007-11-28 | — | — | EP | disclosed |
| EP-1858525-A2 | ORGANIC NITRIC OXIDE DONOR SALTS OF ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2007-11-28 | — | — | EP | disclosed |
| EP-1855688-A2 | NITRIC OXIDE ENHANCING DIURETIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2007-11-21 | — | — | EP | disclosed |
| WO-2007123818-A2 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF PROSTAGLANDINS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007120555-A2 | ASSESSMENT OF HEART FAILURE RISK USING GENETIC ASSESSMENT OF G-PROTEIN BETA-3 SUBUNIT POLYMORPHISM | NITROMED, INC, (US) | 2007-10-25 | — | — | WO | disclosed |
| EP-1846380-A1 | CARDIOVASCULAR COMPOUNDS COMPRISING HETEROCYCLIC NITRIC OXIDE DONOR GROUP COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2007-10-24 | — | — | EP | disclosed |
| US-7282519-B2 | Nitrosated and nitrosylated diuretic compounds, compositions and methods of use | NITROMED, INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-20070238740-A1 | Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use | NITROMED, INC. (US) | 2007-10-11 | — | — | US | disclosed |
| EP-1828155-A2 | DIURETIC COMPOUNDS COMPRISING HETEROCYCLIC NITRIC OXIDE DONOR GROUPS,COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2007-09-05 | — | — | EP | disclosed |
| US-20070191377-A1 | Methods for treating blood disorders with nitric oxide donor compounds | NITROMED, INC. (US) | 2007-08-16 | — | — | US | disclosed |
| EP-1814535-A2 | NITROSATED AND NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPHTHALMIC DISORDERS | Nitromed, Inc. (US) | 2007-08-08 | — | — | EP | disclosed |
| WO-2007086884-A2 | ORGANIC NITRIC OXIDE DONOR SALTS OF ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2007-08-02 | — | — | WO | disclosed |
| WO-2007075542-A2 | NITRIC OXIDE ENHANCING PYRUVATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007075541-A2 | NITRIC OXIDE ENHANCING GLUTAMIC ACID COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007059311-A2 | FUROXAN COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2007-05-24 | — | — | WO | disclosed |
| WO-2007041680-A2 | THE GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF BETA 1 ADRENERGIC RECEPTOR GLY389ARG POLYMORPHISM | NITROMED, INC. (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007041676-A2 | THE GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF ALDOSTERONE SYNTHASE PROMOTER POLYMORPHISM | NITROMED, INC. (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007019448-A2 | NITRIC OXIDE ENHANCING ANGIOTENSIN II ANTAGONIST COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2007-02-15 | — | — | WO | disclosed |
| US-20070037821-A1 | Nitrosated glutamic acid compounds, compositions and methods of use | NITROMED, INC. (US) | 2007-02-15 | — | — | US | disclosed |
| WO-2007016095-A2 | CYCLOOXYGENASE-2 SELECTIVE INHIBITOR COMPOUNDS COMPRISING NITRIC OXIDE ENHANCING GROUPS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| WO-2007016136-A2 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITONS AND METHODS OF USE | NITROMED, INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| WO-2007016677-A2 | NITRIC OXIDE ENHANCING ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| US-20070032533-A1 | Nitric oxide enhancing angiotensin II antagonist compounds, compositions and methods of use | NITROMED, INC. (US) | 2007-02-08 | — | — | US | disclosed |
| EP-1673384-A4 | NITROSATED GLUTAMIC ACID COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2007-02-07 | — | — | EP | disclosed |
| EP-1746882-A2 | METHODS FOR TREATING BLOOD DISORDERS WITH NITRIC OXIDE DONOR COMPOUNDS | Nitromed, Inc. (US) | 2007-01-31 | — | — | EP | disclosed |
| WO-2006127591-A2 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-11-30 | — | — | WO | disclosed |
| EP-1718286-A2 | NITROSATED AND/OR NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2006-11-08 | — | — | EP | disclosed |
| WO-2006110601-A2 | THE GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF THE GENETIC VARIATION OF NOS3 | NITROMED, INC. (US) | 2006-10-19 | — | — | WO | disclosed |
| US-20060229471-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2006-10-12 | — | — | US | disclosed |
| WO-2006102071-A1 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-09-28 | — | — | WO | disclosed |
| WO-2006099058-A2 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF ANGIOTENSIN II ANTAGONISTS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-09-21 | — | — | WO | disclosed |
| WO-2006099416-A1 | 2-METHYL INDOLE CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-09-21 | — | — | WO | disclosed |
| CN-1835800-A | Oxidation catalyst | ASAHI CHEMICAL CORP (JP) | 2006-09-20 | — | — | CN | disclosed |
| WO-2006093864-A1 | CARDIOVASCULAR COMPOUNDS COMPRISING NITRIC OXIDE ENHANCING GROUPS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-09-08 | — | — | WO | disclosed |
| WO-2006091716-A2 | NITRIC OXIDE ENHANCING DIURETIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-08-31 | — | — | WO | disclosed |
| US-20060189603-A1 | such as 2H-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[5-(nitrooxy)pentyl]-, 1,1-dioxide; contains at least one nitric oxide enhancing group; excessive water or electrolyte retention conditions; cardiovascular diseases, and diseases resulting from oxidative or endothelial dysfunctions | NITROMED, INC. (US) | 2006-08-24 | — | — | US | disclosed |
| EP-1692107-A2 | NITRIC OXIDE RELEASING PYRUVATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2006-08-23 | — | — | EP | disclosed |
| WO-2006078995-A1 | CARDIOVASCULAR COMPOUNDS COMPRISING HETEROCYCLIC NITRIC OXIDE DONOR GROUP COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-07-27 | — | — | WO | disclosed |
| EP-1673384-A2 | NITROSATED GLUTAMIC ACID COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2006-06-28 | — | — | EP | disclosed |
| EP-1670459-A2 | NITROSATED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2006-06-21 | — | — | EP | disclosed |
| EP-1668008-A2 | NITROSATED AD NITROSYLATED DIURETIC COMPOUDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2006-06-14 | — | — | EP | disclosed |
| EP-1667643-A2 | NITROSATED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2006-06-14 | — | — | EP | disclosed |
| US-7057030-B2 | Rhodococcus gene encoding aldoxime dehydratase | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-06-06 | — | — | US | disclosed |
| WO-2006055542-A2 | DIURETIC COMPOUNDS COMPRISING HETEROCYCLIC NITRIC OXIDE DONOR GROUPS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-05-26 | — | — | WO | disclosed |
| WO-2006052899-A2 | NITROSATED AND NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPHTHALMIC DISORDERS | NITROMED, INC. (US) | 2006-05-18 | — | — | WO | disclosed |
| EP-1655070-A1 | OXIDATION CATALYST | Asahi Kasei Chemicals Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
| WO-2006041855-A2 | COMPOSITIONS AND METHODS USING APOCYNIN COMPOUNDS AND NITRIC OXIDE DONORS | NITROMED, INC. (US) | 2006-04-20 | — | — | WO | disclosed |
| US-20060009431-A1 | Nitrosated and nitrosylated compounds, compositions and methods use | NITROMED, INC. (US) | 2006-01-12 | — | — | US | disclosed |
| EP-1603933-A2 | NITROSATED AND NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2005-12-14 | — | — | EP | disclosed |
| WO-2005107384-A2 | METHODS FOR TREATING BLOOD DISORDERS WITH NITRIC OXIDE DONOR COMPOUNDS | NITROMED, INC. (US) | 2005-11-17 | — | — | WO | disclosed |
| CN-1670016-A | Arylpyrrole compound with insecticidal, acaricidal and fungicidal biological activity and preparation method thereof | HUNAN RES INST OF CHEMICAL IND (CN) | 2005-09-21 | — | — | CN | disclosed |
| CN-1660822-A | Oxime functionalized new type compound of kinitrogen cyclic amine and synthetic method | TIANJIN TEACHER S UNIV (CN) | 2005-08-31 | — | — | CN | disclosed |
| WO-2005070006-A2 | NITROSATED AND/OR NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-08-04 | — | — | WO | disclosed |
| WO-2005060603-A2 | NITRIC OXIDE RELEASING PYRUVATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-07-07 | — | — | WO | disclosed |
| WO-2005030135-A2 | NITROSATED GLUTAMIC ACID COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-04-07 | — | — | WO | disclosed |
| WO-2005023183-A2 | NITROSATED AD NITROSYLATED DIURETIC COMPOUDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-03-17 | — | — | WO | disclosed |
| US-20050059655-A1 | Nitrosated and nitrosylated diuretic compounds, compositions and methods of use | NITROMED, INC. (US) | 2005-03-17 | — | — | US | disclosed |
| WO-2005023182-A2 | NITROSATED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-03-17 | — | — | WO | disclosed |
| WO-2005018561-A2 | NITROSATED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-03-03 | — | — | WO | disclosed |
| CN-1176918-C | Alpha-substituted benzene acetic acid its preparation and farm pesticide containing said compound | ��Ұ����ҩ��ʽ���� | 2004-11-24 | — | — | CN | disclosed |
| WO-2004098538-A2 | NITROSATED AND NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2004-11-18 | — | — | WO | disclosed |
| US-20030215929-A1 | Rhodococcus gene encoding aldoxime dehydratase | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-11-20 | — | — | US | disclosed |
| CN-1105703-C | Alpha-substituted phenylacetic acid derivatives, their preparation and agricultural fungicides containing the same | SHIONOGI & CO (JP) | 2003-04-16 | — | — | CN | disclosed |
| CN-1394846-A | Alpha-substituted benzene acetic acid its preparation and farm pesticide containing said compound | SHIONOGI & CO (JP) | 2003-02-05 | — | — | CN | disclosed |
| US-6313150-B1 | FOR CONTROLLING PHYTOPATHOGENIC FUNGI | SHIONOGI & CO., LTD. (JP) | 2001-11-06 | — | — | US | disclosed |
| EP-0754672-B1 | GAMMA-SUBSTITUTED PHENYLACETIC ACID DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND AGRICULTURAL BACTERICIDE CONTAINING THE SAME | SHIONOGI & CO (JP) | 2000-10-11 | — | — | EP | disclosed |
| WO-2000011954-A1 | HERBICIDAL METHOD | AVENTIS CROPSCIENCE S.A. (FR) | 2000-03-09 | — | — | WO | disclosed |
| US-5948819-A | α-substituted phenylacetic acid derivative, its production and agricultural fungicide containing it | SHIONOGI & CO., LTD (JP) | 1999-09-07 | — | — | US | disclosed |
| US-5856560-A | REACTING ACYL CYANIDE BENZENE COMPOUND WITH AN ALCOHOL; THEN AN HYDROXYLAMINE; METHYLATION | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-05 | — | — | US | disclosed |
| CN-1161687-A | Phenylacetic acid alkyl esters | BASF AG (DE) | 1997-10-08 | — | — | CN | disclosed |
| EP-0564984-B1 | O-iminooxymethylbenzoic acids, their preparation and use as intermediates | BASF AG (DE) | 1997-08-20 | — | — | EP | disclosed |
| CN-1145061-A | Alpha-substituted phenylacetic acid derivatives, their preparation and agricultural fungicides containing the same | SHIONOGI & CO (JP) | 1997-03-12 | — | — | CN | disclosed |
| EP-0481182-B1 | Bis- and tris(trifluoromethyl) arylpyrrole insecticidal and acaricidal agents | AMERICAN CYANAMID CO (US) | 1997-01-29 | — | — | EP | disclosed |
| EP-0754672-A1 | GAMMA-SUBSTITUTED PHENYLACETIC ACID DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND AGRICULTURAL BACTERICIDE CONTAINING THE SAME | SHIONOGI & CO., LTD. (JP) | 1997-01-22 | — | — | EP | disclosed |
| US-5573999-A | FUNGICIDES AND INSECTICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-11-12 | — | — | US | disclosed |
| US-5538940-A | FUNGICIDE, MITICIDE, INSECTICIDE | BASF AKTIENGESELLSCHAFT (DE) | 1996-07-23 | — | — | US | disclosed |
| US-5530156-A | INTERMEDIATES FOR FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-06-25 | — | — | US | disclosed |
| EP-0293058-B1 | A positive photosensitive resinous composition | NIPPON PAINT CO LTD (JP) | 1995-08-30 | — | — | EP | disclosed |
| US-5393920-A | Reacting oxime with lactone in presence of base | BASF AKTIENGESELLSCHAFT (DE) | 1995-02-28 | — | — | US | disclosed |
| US-5281719-A | Reacting a methyl N-((trimethylsilyl)methyl)thiobenzimidate with 2,3-dichloro-hexafluorobutene to give a 2-aryl-3,4-bis-(trifluoromethyl)pyrrole and reacting this with a halogenating compound | AMERICAN CYANAMID COMPANY (US) | 1994-01-25 | — | — | US | disclosed |
| EP-0564984-A2 | Process for the preparation of O-iminooxymethylbenzoic acid | BASF Aktiengesellschaft (DE) | 1993-10-13 | — | — | EP | disclosed |
| US-5229524-A | Bis-and tris (trifluoromethyl) arylpyrrole insecticidal and acaricidal agents | AMERICAN CYANAMID COMPANY (US) | 1993-07-20 | — | — | US | disclosed |
| US-5157047-A | Miticides | AMERICAN CYANAMID COMPANY (US) | 1992-10-20 | — | — | US | disclosed |
| EP-0343791-B1 | STABILITY-IMPROVED TRIOXANE COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1992-07-29 | — | — | EP | disclosed |
| EP-0481182-A1 | Bis- and tris(trifluoromethyl) arylpyrrole insecticidal and acaricidal agents | AMERICAN CYANAMID COMPANY (US) | 1992-04-22 | — | — | EP | disclosed |
| US-5026875-A | Having ketoxime stabilizers; nondegradating, nonpolymerizing, formaldehyde-free | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1991-06-25 | — | — | US | disclosed |
| US-4869995-A | Positive type photosensitive resinous composition | NIPPON PAINT CO., LTD. (JP) | 1989-09-26 | — | — | US | disclosed |
| EP-0293058-A2 | A positive photosensitive resinous composition | Nippon Paint Co., Ltd. (JP) | 1988-11-30 | — | — | EP | disclosed |
| US-4342763-A | USEFUL AS ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS AND ANTITUSSIVE AGENTS | PROVESAN S.A. (CH) | 1982-08-03 | — | — | US | disclosed |
| US-4342763-A | USEFUL AS ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS AND ANTITUSSIVE AGENTS | PROVESAN S.A. (CH) | 1982-08-03 | — | — | US | disclosed |
| US-4342763-A | USEFUL AS ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS AND ANTITUSSIVE AGENTS | PROVESAN S.A. (CH) | 1982-08-03 | — | — | US | disclosed |
| US-4317835-A | ANTIINFLAMMATERY, ANALGESIC | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1982-03-02 | — | — | US | disclosed |
| US-4242348-A | ANALGESICS; ANTIIFLAMMATORY AGENTS | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1980-12-30 | — | — | US | disclosed |
| US-4196216-A | ANTIINFLAMMATORY AGENTS, ANALGESICS | U.S. PHILIPS CORPORATION (US) | 1980-04-01 | — | — | US | disclosed |
| US-4124227-A | Oxime ethers of Michler's hydrol, method of producing same and pressure-sensitive recording systems containing such compounds | MOORE BUSINESS FORMS, INC. (US) | 1978-11-07 | — | — | US | disclosed |
| US-4086243-A | Intermediates in the preparation of isoxazolyl benzamides | SANDOZ, INC. (US) | 1978-04-25 | — | — | US | disclosed |
| US-4071686-A | ANTIINFLAMMATORY, ANALGESIC | U.S. PHILIPS CORPORATION (US) | 1978-01-31 | — | — | US | disclosed |
| US-4044023-A | ANTIINFLAMMATORY, ANALGESICS | U.S. PHILIPS CORPORATION (US) | 1977-08-23 | — | — | US | disclosed |
| US-3987179-A | ISOXAZOLYL BENZAMIDES AS PHARMACOLOGICAL AGENTS | SANDOZ, INC. (US) | 1976-10-19 | — | — | US | disclosed |
| US-3987179-A | ISOXAZOLYL BENZAMIDES AS PHARMACOLOGICAL AGENTS | SANDOZ, INC. (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (33 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293702-A1 | Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use | PC, PDK1, NOS3 | LMNA 812/4885POLB 2802/4885KMT2A 3491/4885 |
| US-20090048219-A1 | ORGANIC NITRIC OXIDE DONOR SALTS OF NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NOS3, NOS1, NOS2 | LMNA 4765/4885POLB 2741/4885KMT2A 4643/4885 |
| US-20090215838-A1 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF ANGIOTENSIN II ANTAGONISTS, COMPOSITIONS AND METHODS OF USE | NOS2, NOS3, NOS1 | LMNA 1935/4885POLB 2738/4885KMT2A 3944/4885 |
| US-20100240622-A1 | NITRIC OXIDE ENHANCING PROSTAGLANDIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE | PTGIS, NOS2, NOS1 | LMNA 2819/4885POLB 2204/4885KMT2A 4509/4885 |
| US-20090131342-A1 | Nitrosated and/or nitrosylated compounds, compositions and methods of use | LTC4S, LTB4R2, LTB4R | LMNA 3477/4885POLB 1382/4885KMT2A 4569/4885 |
| US-20080300292-A1 | Nitrosated and Nitrosylated Compounds, Compositions and Methods for the Treatment of Ophthalmic Disorders | NOS3, NOS1, NOS2 | LMNA 2394/4885POLB 1563/4885KMT2A 3321/4885 |
| US-20090012057-A1 | Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use | REN, EDNRB, ECE1 | LMNA 440/4885POLB 2873/4885KMT2A 4066/4885 |
| US-20090053328-A1 | Nitric Oxide Enhancing Glutamic Acid Compounds, Compositions and Methods of Use | GLS, NOS1, NOS2 | LMNA 2371/4885POLB 2909/4885KMT2A 3393/4885 |
| US-20090192128-A1 | GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF BETA 1 ADRENERGIC RECEPTOR GLY389ARG POLYMORPHISM | ADRB3, ADRB1, EDNRB | LMNA 2634/4885POLB 1560/4885KMT2A 3355/4885 |
| US-20080275093-A1 | Diuretic Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use | NOS3, NOS1, NOS2 | LMNA 1992/4885POLB 3979/4885KMT2A 4611/4885 |
| US-20070191377-A1 | Methods for treating blood disorders with nitric oxide donor compounds | NOS2, HBZ, QDPR | LMNA 3143/4885POLB 1869/4885KMT2A 2834/4885 |
| US-20060009431-A1 | Nitrosated and nitrosylated compounds, compositions and methods use | TBXA2R, TXNRD3, NOS3 | LMNA 3927/4885POLB 4760/4885KMT2A 3639/4885 |
| US-20080306041-A1 | Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use | REN, NOX5, NOS3 | LMNA 643/4885POLB 2335/4885KMT2A 4302/4885 |
| US-20110195935-A1 | NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE | NOS2, NOS3, NOS1 | LMNA 2524/4885POLB 3068/4885KMT2A 3937/4885 |
| US-20120034321-A1 | NITRIC OXIDE ENHANCING PROSTAGLANDIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE | PTGIS, NOS2, PTGS1 | LMNA 2873/4885POLB 2831/4885KMT2A 4488/4885 |
| US-20090075956-A1 | Genetic Risk Assessment in Heart Failure: Impact of the Genetic Variation of NOS3 | NOS3, NOS2, TNNI3 | LMNA 2627/4885POLB 1488/4885KMT2A 3217/4885 |
| US-20090018091-A1 | Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use | NOS1, NOS3, NOS2 | LMNA 3046/4885POLB 2343/4885KMT2A 3390/4885 |
| US-20100069670-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | LMNA 4861/4885POLB 549/4885KMT2A 1292/4885 |
| US-20070238740-A1 | Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use | REN, ECE1, EDNRA | LMNA 185/4885POLB 3647/4885KMT2A 4254/4885 |
| US-20090203653-A1 | Compositions and Methods Using Apocynin Compounds and Nitric Oxide Donors | NOX4, NOS2, REN | LMNA 3819/4885POLB 3302/4885KMT2A 4749/4885 |
| US-20050059655-A1 | Nitrosated and nitrosylated diuretic compounds, compositions and methods of use | REN, NOS1, NOS3 | LMNA 615/4885POLB 4088/4885KMT2A 4596/4885 |
| US-20080287407-A1 | Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use | PC, PDK1, NOS3 | LMNA 2278/4885POLB 3153/4885KMT2A 3995/4885 |
| US-20090253662-A1 | GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF ALDOSTERONE SYNTHASE PROMOTER POLYMORPHISM | HSD11B2, HSD11B1, CYP11B2 | LMNA 2724/4885POLB 522/4885KMT2A 3270/4885 |
| US-20080268014-A1 | Furoxan Compounds, Compositions and Methods of Use | PTGIS, F3, PTGIR | LMNA 3795/4885POLB 3831/4885KMT2A 4266/4885 |
| US-20070032533-A1 | Nitric oxide enhancing angiotensin II antagonist compounds, compositions and methods of use | AGTR2, AGTR1, REN | LMNA 922/4885POLB 2228/4885KMT2A 3084/4885 |
| US-20140057873-A1 | NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE | NOS2, NOS3, NOS1 | LMNA 2524/4885POLB 3068/4885KMT2A 3937/4885 |
| US-20080293678-A1 | Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use | NOS3, REN, NOS1 | LMNA 2062/4885POLB 1441/4885KMT2A 4143/4885 |
| US-20060189603-A1 | such as 2H-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[5-(nitrooxy)pentyl]-, 1,1-dioxide; contains at least one nitric oxide enhancing group; excessive water or electrolyte retention conditions; cardiovascular diseases, and diseases resulting from oxidative or endothelial dysfunctions | NOS1, NOS3, REN | LMNA 1682/4885POLB 3608/4885KMT2A 3375/4885 |
| US-20070037821-A1 | Nitrosated glutamic acid compounds, compositions and methods of use | GLS, NOS2, NOS1 | LMNA 2015/4885POLB 3471/4885KMT2A 3342/4885 |
| US-20090306027-A1 | GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF THE GENETIC VARIATION OF G-PROTEIN BETA 3 SUBUNIT POLYMORPHISM | ADRB3, GNAI3, GNB1 | LMNA 3721/4885POLB 2054/4885KMT2A 3510/4885 |
| US-20080255101-A1 | NITRIC OXIDE DONATING DIURETIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NOS1, NOS3, NOS2 | LMNA 1174/4885POLB 3387/4885KMT2A 4371/4885 |
| US-20060229471-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | LMNA 4861/4885POLB 549/4885KMT2A 1292/4885 |
| US-20090042819-A1 | Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use | NOS1, NOS2, NOS3 | LMNA 3862/4885POLB 2604/4885KMT2A 3627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.